InvestorsHub Logo
Followers 79
Posts 24611
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 03/27/2024 9:21:14 AM

Wednesday, March 27, 2024 9:21:14 AM

Post# of 27525
LIXT - 2.255 Pre-market at 3.67/3.69

NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.